Physician profile
Waref Azmeh
NPI 1467408492
$2,095.04
in general payments reported to CMS, 2019-2025
12 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $463 · 2021: $98.93 · 2022: $198 · 2023: $447 · 2024: $174 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $551.37 | 2020-2025 | Mytesi |
| Paratek Pharmaceuticals, INC. | $503.24 | 2019-2023 | Nuzyra |
| Viiv Healthcare Company | $374.77 | 2019-2025 | Cabenuva, Rukobia |
| Merck Sharp & Dohme LLC | $171.02 | 2020-2025 | Pifeltro, Delstrigo, Capvaxive |
| Theratechnologies INC. | $135.35 | 2021-2025 | Egrifta, Trogarzo |
| Gilead Sciences, INC. | $110.69 | 2023-2024 | |
| Janssen Products, LP | $99.95 | 2019 | |
| Insmed, INC. | $63.78 | 2020-2025 | Arikayce |
| Janssen Biotech, INC. | $30.21 | 2019 | |
| Allergan, INC. | $23.19 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $18.67 | 2020 | |
| Melinta Therapeutics, LLC | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waref Azmeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.